Your browser doesn't support javascript.
loading
Joint association of patients' sex and PD-L1 expression with overall survival benefits and tumor-immune microenvironment in immune checkpoint inhibitors for cancers.
Li, Anlin; Chen, Yongjian; Zhang, Wenda; Zhong, Haitao; Ou, Qiyun; Gu, Yang; Xia, Junqing; Lin, Dagui; Fu, Tuping; Liu, Ruixin; Hu, Hai; Yu, Yunfang; Yao, Herui.
Affiliation
  • Li A; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Oncology, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Chen Y; Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Zhanjiang, China.
  • Zhang W; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Oncology, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zhong H; Department of Medical Oncology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Ou Q; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Oncology, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Gu Y; Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Zhanjiang, China.
  • Xia J; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Oncology, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Lin D; The First Clinical Medical College, Southern Medical University, Guangzhou, China.
  • Fu T; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Oncology, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Liu R; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Oncology, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Hu H; The First Clinical Medical College, Southern Medical University, Guangzhou, China.
  • Yu Y; Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yao H; Sun Yat-sen University Cancer Center, Guangzhou, China.
Clin Transl Med ; 10(2): e92, 2020 Jun.
Article in En | MEDLINE | ID: mdl-32508054
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Clin Transl Med Year: 2020 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Clin Transl Med Year: 2020 Type: Article Affiliation country: China